Canada markets close in 3 hours 27 minutes

Cyclacel Pharmaceuticals, Inc. (CYCC)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.8726+0.2226 (+8.40%)
As of 12:32PM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 3.53M
Enterprise Value 192.19k
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)5.43
Price/Book (mrq)5.82
Enterprise Value/Revenue 0.46
Enterprise Value/EBITDA -0.01

Trading Information

Stock Price History

Beta (5Y Monthly) 0.57
52-Week Change 3-66.03%
S&P500 52-Week Change 323.57%
52 Week High 313.2000
52 Week Low 31.3000
50-Day Moving Average 32.2222
200-Day Moving Average 34.7129

Share Statistics

Avg Vol (3 month) 3768.02k
Avg Vol (10 day) 34.47M
Shares Outstanding 51.32M
Implied Shares Outstanding 61.32M
Float 81.14M
% Held by Insiders 17.12%
% Held by Institutions 116.73%
Shares Short (Apr 15, 2024) 438.41k
Short Ratio (Apr 15, 2024) 41.21
Short % of Float (Apr 15, 2024) 43.08%
Short % of Shares Outstanding (Apr 15, 2024) 42.91%
Shares Short (prior month Mar 15, 2024) 426.61k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Apr 15, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:15
Last Split Date 3Dec 18, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-17,290.32%

Management Effectiveness

Return on Assets (ttm)-86.33%
Return on Equity (ttm)-272.63%

Income Statement

Revenue (ttm)420k
Revenue Per Share (ttm)0.49
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -25.42M
Net Income Avi to Common (ttm)-22.76M
Diluted EPS (ttm)-26.7500
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.38M
Total Cash Per Share (mrq)2.56
Total Debt (mrq)37k
Total Debt/Equity (mrq)6.10%
Current Ratio (mrq)0.91
Book Value Per Share (mrq)0.57

Cash Flow Statement

Operating Cash Flow (ttm)-16.11M
Levered Free Cash Flow (ttm)-11.76M